同和藥品의 成長과 發展過程

The Process of Growth and Development of Dong-wha Industrial Company

The Purpose of this study is to assess historical growth and development of the Dong-wha Pharmaceutical Industrial Company, which has grown characteristically as the oldest and the first manufacturing firm in the Korean business society. The Dong-wha Pharmaceutical Industrial Co., Ltd. was established on september 25th, 1897 in Seoul. The Company has 110 years old in this year, 2007. The process of the Company’s growth and development is divided chronologically eight distinctive stages as follows : 1) The era of its initial foundation, 2) The stage of its second foundation, 3) The period of establishing basis of enterprise activities, 4) The period of its growth, 5) The period of its development, 6) The period of its take-off stage, 7) The period of its innovation, and 8) The period of its future-oriented challenge. The history of Korea’s modern pharmaceutical industry dates back to 1897 that the Dong-wha Yak Bang(pharmaceutical firm) has been founded by Kang Min at the end of Chosun Dynasty. After that, the Dong-wha pharmaceutical firm has played a trustworthy watcher for people’s better health more than 110 years. This periods has evolved into the enlightened age of the end of Chosun Dynasty, Japanese harsh colonial rule for 36 years, Korean independence in 1945, the time of Korean war in 1950s, the times of economic development by Korean government from 1960s to 1990s, Asian financial crisis in 1997, and new system of separating drug dispensing from medical practice in 2000. So, this study is discussed stage by stage major factors which has contributed to the growth and development of the firm for this periods. Methodologically, it has employed historical analysis and descriptive approach. In this periods, Dong-wha Pharmaceutical Corporation has been experienced a higher growth and development by Chang-Sik Yoon and Kwang-yull Yoon. We has found out Its several factors of its growth in the founder’s entrepreneurship and leadership, CEO’s vision emphasizing creativity, management of righteousness, customer-oriented business, cooperations and challenge spirit, diversification strategy, scientific TQC principle pharmaceutical goods development by R&D activities and technological innovation. and exploitation of market, etc.